Upper limb wounds subcuticular skin closure with Polypropylene et Upper limb wounds subcuticular skin closure with Polyglactin à Compare Cosmetic Outcomes of Subcuticular Skin Closure Using Polypropylene and Polyglactin - Registre des essais cliniques

Aperçu de l'étude

Statut

Recrutement

Les conditions

Compare Cosmetic Outcomes of Subcuticular Skin Closure Using Polypropylene and Polyglactin

Intervention / Traitement

Description détaillée

Background and Rationale Although previous studies have compared absorbable and non-absorbable sutures, most did not specifically evaluate standardized scar outcomes for subcuticular closure in the upper limb. While upper limb wounds may not carry the same aesthetic priority as facial wounds, scars in this region are highly visible and can adversely affect patients' psychological well-being. Subcuticular suturing is commonly used to improve cosmetic outcomes and reduce wound complications. Both Polypropylene (non-absorbable) and Polyglactin (absorbable) are widely used materials, yet their comparative performance in subcuticular skin closure remains controversial.

Aim and Objectives

Primary objective:

- To compare cosmetic outcomes of subcuticular skin closure using Polypropylene and Polyglactin

Secondary objectives:

To compare postoperative wound complication rates (including infection, wound dehiscence, and hematoma formation) between polypropylene and polyglactin sutures
To assess patient-reported discomfort and satisfaction associated with each suture material
To assess the influence of the nature of surgery (elective vs trauma) on wound healing outcomes for each suture type

Type d'étude

Interventionnel

Inscription (Estimé)

100

Phase

N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Nom: Mohamed Elsaid Hamisa
Numéro de téléphone: +201092248136
E-mail: mohamedhamisa442@gmail.com

Lieux d'étude

Egypte
- - Menoufia Governorate, Egypte, 33511
    - Recrutement
    - Shebin El Koum teaching Hospital
    - Contact:
      
      Mohamed Elsaid Hamisa
      
      Numéro de téléphone: +201092248136
      
      E-mail: mohamedhamisa442@gmail.com

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

Adulte
Adulte plus âgé

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

Adults aged ≥18 years
Patients undergoing any surgical procedure involving the upper limb
Procedures performed in either elective or emergency settings
Wounds suitable for primary subcuticular skin closure
Ability to provide informed consent

Exclusion Criteria:

Heavily contaminated or infected wounds
Patients with uncontrolled diabetes mellitus, chronic steroid use, immunosuppression or peripheral vascular disease
Crush injuries and wounds with significant tissue loss
Known allergy to suture material
Delayed primary closure wounds

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Objectif principal: Traitement
Répartition: Randomisé
Modèle interventionnel: Affectation parallèle
Masquage: Seul

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats	Description de la mesure	Délai
Cosmetic outcome measured using the Patient and Observer Scar Assessment Scale (POSAS) total score (range 6-60) Délai: Baseline	Scar quality will be evaluated using the Patient and Observer Scar Assessment Scale (POSAS), which includes both patient-reported and observer-reported components. Each item is scored from 1 to 10, with total scores ranging from 6 to 60, where lower scores indicate better cosmetic outcome.	Baseline

Mesures de résultats secondaires

Mesure des résultats	Description de la mesure	Délai
Incidence of surgical site infection (SSI) (number and percentage of patients) Délai: Baseline	Surgical site infection will be assessed based on clinical criteria including the presence of purulent discharge, localized swelling, erythema, warmth, or wound dehiscence, with or without positive bacterial culture. The outcome will be reported as the number and percentage of patients who develop SSI during the follow-up period.	Baseline
Incidence of wound dehiscence (number and percentage of patients) Délai: Baseline	Wound dehiscence will be defined as partial or complete separation of the surgical wound edges after closure. The outcome will be assessed clinically during follow-up visits and reported as the number and percentage of patients who develop wound dehiscence.	Baseline
Incidence of hematoma formation (number and percentage of patients) Délai: Baseline	Hematoma formation will be defined as a localized collection of blood at the surgical site, identified clinically by swelling, discoloration, or tension, with or without the need for evacuation. The outcome will be assessed during follow-up and reported as the number and percentage of patients who develop a hematoma.	Baseline
Patient satisfaction measured using a 5-point Likert scale (score range 1-5) Délai: Baseline	Patient satisfaction will be assessed using a 5-point Likert scale, where 1 indicates very dissatisfied and 5 indicates very satisfied. The outcome will be reported as a numerical score reflecting the patient's overall satisfaction with the surgical result.	Baseline

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Shebin El-Kom Teaching Hospital

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW, van Zuijlen PP. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg. 2004 Jun;113(7):1960-5; discussion 1966-7. doi: 10.1097/01.prs.0000122207.28773.56.
Hanna AJ, Sonnier JH, Coladonato C, Destine H, Wilson S, Ciccotti MG, Tjoumakaris FP, Freedman KB. Greater Patient Satisfaction With Use of Nonabsorbable Sutures Compared to Absorbable Sutures for Skin Closure Following Knee Arthroscopy: A Randomized Controlled Trial. Arthrosc Sports Med Rehabil. 2023 Nov 10;5(6):100814. doi: 10.1016/j.asmr.2023.100814. eCollection 2023 Dec.
Ramadan MS, Elhosseiny AS, Sabaa HA, Nassar SA. Evaluation of the effect of subcuticular skin closure with absorbable suture, polyglactin 910 (Vicryl), versus non-absorbable suture, polypropylene (Prolene), on the risk of wound infection and complications after caesarean section. QJM: An International Journal of Medicine. 2025;118(Suppl_1):hcaf224.173. doi:10.1093/qjmed/hcaf224.173
Hasdemir PS, Guvenal T, Ozcakir HT, Koyuncu FM, Dinc Horasan G, Erkan M, Oruc Koltan S. Comparison of Subcuticular Suture Materials in Cesarean Skin Closure. Surg Res Pract. 2015;2015:141203. doi: 10.1155/2015/141203. Epub 2015 Aug 27.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 mai 2026

Achèvement primaire (Estimé)

1 mai 2027

Achèvement de l'étude (Estimé)

1 novembre 2027

Dates d'inscription aux études

Première soumission

21 avril 2026

Première soumission répondant aux critères de contrôle qualité

11 mai 2026

Première publication (Réel)

13 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)